MTIP
SCMP

Magee Thomson Investment Partners’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Magee Thomson Investment Partners’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-20,567
Closed -$148K – 169
2014
Q1 		$148K Hold
20,567
– – 0.03% 83
2013
Q4 		$194K Buy
20,567
+8,569
+71% +$61.1K 0.04% 73
2013
Q3 		$74K Hold
11,998
– – 0.01% 88
2013
Q2 		$78K Buy
+11,998
New +$95.2K 0.02% 83

Other funds holding SCMP

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Magee Thomson Investment Partners's SCMP Position: Q2 2014 in Review

Magee Thomson Investment Partners sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2014, closing a stake of 20,567 shares — an estimated $148K sold.

Magee Thomson Investment Partners first reported a position in SCMP in Q2 2013 and held it in 4 quarters. The position peaked at $194K in Q4 2013. 71 funds tracked by Wall St. Rank hold SCMP as of Q2 2014.

  • Magee Thomson Investment Partners reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • Magee Thomson Investment Partners sold 20,567 Sucampo Pharmaceuticals, Inc. shares in Q2 2014, an estimated $148K.
  • Magee Thomson Investment Partners first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
  • Magee Thomson Investment Partners's Sucampo Pharmaceuticals, Inc. position peaked at $194K in Q4 2013.
  • 71 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2014.

Based on Magee Thomson Investment Partners's 13F filing for Q2 2014, filed 29 Jul 2014.